| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8746084 | Journal of Global Antimicrobial Resistance | 2018 | 27 Pages |
Abstract
Whilst most results are similar to other large surveys of fungal susceptibility, the new CLSI interpretive criteria significantly altered the proportion of non-susceptible isolates to fluconazole, voriconazole and caspofungin for several Candida spp. Application of CLSI and YeastOne-derived ECVs revealed the presence of a low proportion of non-WT isolates for many species. The results serve as a baseline to monitor the susceptibility of Candida and other yeast species in New Zealand over time.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Arthur J. Morris, Karen Rogers, Wendy P. McKinney, Sally A. Roberts, Joshua T. Freeman,